Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Democrats Slam Trump’s ‘Sledgehammer’ On FDA
Jul 28 2025
•
By
Malcolm Spicer
California’s Nanette Diaz Barragán displays FDA organization charge during Energy and Comme markup of reauthorizing OMUFA.
(Source: screenshot from House broadcast)
More from Legislation
More from Policy & Regulation